GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bright Minds Biosciences Inc (XCNQ:DRUG) » Definitions » 3-Year ROIIC %

Bright Minds Biosciences (XCNQ:DRUG) 3-Year ROIIC % : -5,007.97% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Bright Minds Biosciences 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Bright Minds Biosciences's 3-Year ROIIC % for the quarter that ended in Sep. 2023 was -5,007.97%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Bright Minds Biosciences's 3-Year ROIIC % or its related term are showing as below:

XCNQ:DRUG's 3-Year ROIIC % is ranked worse than
98.1% of 1419 companies
in the Biotechnology industry
Industry Median: -16.71 vs XCNQ:DRUG: -5007.97

Bright Minds Biosciences 3-Year ROIIC % Historical Data

The historical data trend for Bright Minds Biosciences's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bright Minds Biosciences 3-Year ROIIC % Chart

Bright Minds Biosciences Annual Data
Trend Sep20 Sep21 Sep22 Sep23
3-Year ROIIC %
- - - -5,007.97

Bright Minds Biosciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -5,007.97 -

Competitive Comparison of Bright Minds Biosciences's 3-Year ROIIC %

For the Biotechnology subindustry, Bright Minds Biosciences's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bright Minds Biosciences's 3-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bright Minds Biosciences's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Bright Minds Biosciences's 3-Year ROIIC % falls into.



Bright Minds Biosciences 3-Year ROIIC % Calculation

Bright Minds Biosciences's 3-Year ROIIC % for the quarter that ended in Sep. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -7.386 (Sep. 2023) - -0.475 (Sep. 2020) )/( 0.14 (Sep. 2023) - 0.002 (Sep. 2020) )
=-6.911/0.138
=-5,007.97%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Bright Minds Biosciences  (XCNQ:DRUG) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Bright Minds Biosciences 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Bright Minds Biosciences's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bright Minds Biosciences (XCNQ:DRUG) Business Description

Traded in Other Exchanges
Address
19 Vestry Street, New York, NY, USA, 10013
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Bright Minds Biosciences (XCNQ:DRUG) Headlines